Gerald Clarke | 11/13/2013
Pharma IQ interviewed Adrian Peskett, Clinical Supply Logistics Director at Pfizer Ltd. about his predictions for the future of clinical trial supply in emerging markets. Adrian also speaks about the importance of forecasting in emerging markets and the difficulties in standardising strategy, while meeting countries' individual needs.
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More